Skip to content

Effectiveness and Adoption of the TelTex4BP Intervention Among Adults With Hypertension in Nepal

Effectiveness and Adoption of the Structured mHealth Intervention for Improving Blood Pressure Control (TelTex4BP) Among Adults With Hypertension in Nepal: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05979168
Acronym
TelTex4BP
Enrollment
500
Registered
2023-08-07
Start date
2025-11-02
Completion date
2027-12-31
Last updated
2026-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Cardiovascular Diseases, Hypertension, Medication Adherence

Keywords

Mobile Intervention, Blood Pressure Control, Hypertension, Randomized Controlled Trial

Brief summary

Despite evidence of preventing cardiovascular disease (CVD) risk through lifestyle changes, many patients with hypertension (HTN) do not comply with this and suffer from CVD and other complications. A previous study using a structured lifestyle intervention program has reported a 14% decrease in the 10-year risk of developing CVD at one year among hypertensive and diabetes patients. Low and Middle-Income countries (LMICs) struggle with a shortage of health workers to deliver such interventions. In this context, mobile phones can contribute to bridging this gap by incorporating them into the health system for health intervention delivery. There is a need to develop contextual mHealth intervention adapted to local needs and culture and test its effectiveness in LMIC settings like Nepal. Our previous small-scale pilot mHealth (text messages) study reported promising evidence in reducing blood pressure among hypertensive patients in the intervention arm \[adjusted reduction in systolic blood pressure (BP) -6.50 (95% CI, -12.6; -0.33) and diastolic BP -4.60 (95% CI, -8.16; -1.04)\], with a greater proportion achieving target BP (70% vs 48% in the control arm, p = 0.006)\] and improving treatment compliance (p \< 0.001) in Nepal. This finding supports the expansion to a large-scale trial of a structured mHealth intervention to see its long-term effectiveness and sustainability for patients with HTN to improve BP control and reduce CVD risk. Hence, this study aims to assess the effectiveness of a behavioural intervention through mHealth (telephone/mobile phone calls and text messages) informed by the RE-AIM framework for improving blood pressure control among patients with hypertension in a hospital (Manamohan Cardiothoracic Vascular and Transplant Center) of Kathmandu, Nepal.

Detailed description

This study will be a hybrid type 2 effectiveness-implementation study using mixed methods, a parallel randomized controlled trial with a nested qualitative design. The intervention will be codesigned involving patients, their family members, and healthcare providers to incorporate their views, the local context and culture through a formative qualitative component informed by the CFIR. A multi-component mHealth intervention will be delivered through text messages and phone calls (TelTex4BP) by nurses, focusing on behaviour changes (physical activity, healthy diet), medication adherence, a reminder for follow-up, smoking, and alcohol intake. The intervention will be delivered for six months, and follow-up will be carried out at the end of the intervention and six months later (at one year) to assess sustainability and long-term effectiveness. Clinical (blood pressure, 10-year risk of CVD), intermediate (medication adherence, change of dietary habits/physical activity), and implementational outcomes ( Reach, Adoption, Intervention fidelity and Maintenance) will be evaluated using the RE-AIM framework. If the intervention is proven effective, the study findings will be disseminated to promote scaling up to other similar settings.

Interventions

BEHAVIORALPhone call and text Messages

The intervention consists of recommended lifestyle counselling (on a healthy diet, physical activity, smoking, alcohol intake, medication adherence and continuity of care). This counselling will be provided through the research nurse at baseline and for six months (tentative plan phone call once a month; frequency and duration will be finalized based on formative study) by calling on participants' given mobile numbers. In addition, text message reminders on the same topics will be delivered regularly (2-3 times a week) for six months. The counselling and message will focus on three domains of COM-B; capabilities needed, opportunities and practical tools, and motivation strategies informed by behaviour change techniques.

Sponsors

Central Department of Public Health
Lead SponsorOTHER
Harvard School of Public Health (HSPH)
CollaboratorOTHER
Apara Innovations Pvt. Ltd
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

This study will use a two-arm parallel-group, individually randomized control trial design to test the effectiveness of a TelTex4BP intervention compared to standard care at one year among diagnosed patients of HTN.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Clinical diagnosis of hypertension * Currently receiving/prescribed blood pressure-lowering medication for more than three months * With uncontrolled blood pressure (\>130/80mm of Hg) * Should have access to a mobile phone * Able to read text messages ( by themselves/with the help of family)

Exclusion criteria

* Diagnosed with myocardial infarction, stroke, and kidney failure * Severe mental illness, cognitive impairment * Pregnant women or in the postpartum period

Design outcomes

Primary

MeasureTime frameDescription
Systolic Blood Pressurebaseline, 6 and 12 monthsAverage of last of two measures of Blood pressure.

Secondary

MeasureTime frameDescription
Blood Pressure ControlBaseline, 6 and 12 monthsMeasures of Systolic and diastolic BP
10 year risk of development of CVDBaseline, 6 and 12 monthsGlobo CVD risk calculator
Medication adherenceBaseline, 6 and 12 monthsHill-Bone compliance to high blood pressure therapy scale will be use to measure adherence to antihypertensive therapy. This tool contains 14 items: nine items related to medication, three items on salt intake and two items on appointment keeping. Each item is scored on a response of 1-4. The total score of Hill Bone is 56 where a lower score indicates higher adherence to antihypertensive therapy.
Dietary habits (salt intake, fruits and vegetables intake)Baseline, 6 and 12 monthsDietary salt \[9 items\] based on the WHO STEPs survey
Physical activityBaseline, 6 and 12 monthsPhysical activity \[17 items\]based on the WHO STEPs survey

Countries

Nepal

Contacts

CONTACTBuna Bhandari, PhD
buna.bhandari@gmail.com8508156644
CONTACTRabina Dhakal, MPH
dhakalrabina@gmail.com977 9841075217
PRINCIPAL_INVESTIGATORBuna Bhandari Bhattarai, PhD

Indiana University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 9, 2026